AQR Capital Management’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-25,334
| Closed | -$742K | – | 2317 |
|
|
2017
Q3 | $742K | Sell |
25,334
-18,134
| -42% | -$508K | ﹤0.01% | 1784 |
|
|
2017
Q2 | $1.14M | Sell |
43,468
-32,097
| -42% | -$789K | ﹤0.01% | 1624 |
|
|
2017
Q1 | $1.77M | Buy |
75,565
+10,780
| +17% | +$266K | ﹤0.01% | 1433 |
|
|
2016
Q4 | $1.63M | Sell |
64,785
-7,784
| -11% | -$197K | ﹤0.01% | 1504 |
|
|
2016
Q3 | $2.04M | Sell |
72,569
-67,302
| -48% | -$1.73M | ﹤0.01% | 1408 |
|
|
2016
Q2 | $3.45M | Sell |
139,871
-77,473
| -36% | -$1.92M | 0.01% | 1059 |
|
|
2016
Q1 | $4.81M | Buy |
217,344
+44,301
| +26% | +$1.18M | 0.01% | 898 |
|
|
2015
Q4 | $6.06M | Buy |
173,043
+63,207
| +58% | +$1.98M | 0.01% | 856 |
|
|
2015
Q3 | $3.13M | Sell |
109,836
-43,909
| -29% | -$1.48M | 0.01% | 950 |
|
|
2015
Q2 | $5.12M | Sell |
153,745
-111,293
| -42% | -$3.42M | 0.01% | 824 |
|
|
2015
Q1 | $7.47M | Sell |
265,038
-188,800
| -42% | -$4.69M | 0.02% | 639 |
|
|
2014
Q4 | $9.4M | Buy |
453,838
+40,853
| +10% | +$970K | 0.02% | 684 |
|
|
2014
Q3 | $10.1M | Sell |
412,985
-41,800
| -9% | -$1.11M | 0.03% | 594 |
|
|
2014
Q2 | $13M | Buy |
454,785
+45,900
| +11% | +$1.28M | 0.04% | 549 |
|
|
2014
Q1 | $11.4M | Buy |
408,885
+116,700
| +40% | +$2.87M | 0.03% | 539 |
|
|
2013
Q4 | $6.28M | Sell |
292,185
-48,294
| -14% | -$878K | 0.02% | 778 |
|
|
2013
Q3 | $4.52M | Sell |
340,479
-164,389
| -33% | -$2.21M | 0.02% | 853 |
|
|
2013
Q2 | $7M | Buy |
+504,868
| New | +$7.15M | 0.02% | 722 |
|
AQR Capital Management's PMC Position: Q4 2017 in Review
AQR Capital Management sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 25,334 shares — an estimated $742K sold.
AQR Capital Management first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $13M in Q2 2014. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- AQR Capital Management reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- AQR Capital Management sold 25,334 PharMerica Corporation shares in Q4 2017, an estimated $742K.
- AQR Capital Management first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- AQR Capital Management's PharMerica Corporation position peaked at $13M in Q2 2014.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on AQR Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.